Targeted gene inactivation in the mouse affords a direct experimental means of addressing whether highly related members of a multigene family have unique or overlapping roles. Such a strategy has been utilized with the goal of delineating the functions of each member of the Myc family in the developing mouse (14, 16, 58, 66 ; also the present report). The myc family of cellular oncogenes encodes three structurally and functionally related members, c-Myc, N-Myc, and L-Myc, that are believed to play key roles in the regulation of cellular proliferation, differentiation, and apoptosis (19, 22, 38) . Although their precise mechanism of action remains to be fully elucidated, current evidence supports the view that Myc oncoproteins function as sequence-specific transcription factors governing the regulation of target genes integral to these processes (for reviews, see reference 68 and references therein).
The c-myc gene was first identified as the cellular homolog of an avian retrovirus transforming gene, v-myc (64, 65) . Identification of the N-myc gene was made possible on the basis of its homology to c-myc and its amplification in human neuroblastomas (18, 32, 33, 62) . Similarly, L-myc was identified as a myc-related sequence amplified in a subset of human small-cell lung carcinomas (30, 50) and then independently isolated from normal murine and human genomes on the basis of homology to N-myc (17, 36) . Members of the Myc family share features in their gene and protein structures, including (i) a three-exon gene organization that gives rise to short-lived transcripts with large 5Ј and 3Ј untranslated regions and (ii) nucleus-localized, related gene products with the capacity to bind DNA in a sequence-specific manner (10, 53) , transactivate gene expression in vitro (2, 5, 12, 28) , and oligomerize with another basic region-helix-loop-helix-leucine zipper (bHLH/LZ) protein, Max (1, 6, 11, 29, 49, 52, 71) . On the biological level, all three myc family genes can cooperate with a mutant H-RAS gene to transform early-passage rat embryo fibroblasts (17, 35, 63, 73) and can generate tumors when overexpressed in transgenic mice (for a review, see reference 43) . The use of dominantnegative mutant forms of Myc has revealed that members of the Myc family function through common genetic pathways to transform cells (49) .
Several lines of evidence support the view that the members of the myc family have separable physiological functions, including (i) their conservation as distinct genes over a large phylogenetic distance from zebra fish to humans (reference 60 and references therein; 61), (ii) their dispersed chromosomal locations (reviewed in reference 44), and (iii) marked differences in their oncogenic and transactivation potencies, with c-Myc possessing strong activity and N-and L-Myc exhibiting moderate and weak transforming and transactivation potential, respectively (4, 9, 17, 49, 72) . Support for their unique and essential roles in development also stems from their distinct patterns of expression with respect to cell type and developmental stage; however, extensive overlap in myc family gene expression does exist (for a review, see reference 19) .
During development, expression of c-, N-, and L-myc is at its highest levels during embryonic stages and is downregulated as mature organ systems become growth arrested and terminally differentiate postnatally. Although transcripts of all three genes are detectable in preimplantation embryos (24a), with the onset of gastrulation, the N-myc gene is abundantly expressed in embryonic cells while c-myc transcripts predominate in extraembryonic tissues (21) . As development progresses through midgestation, the distribution of N-myc transcripts becomes restricted to particular organs (such as the brain and kidney) while that of c-myc is more broad (21, 47, 59) . Notably, L-myc has a more limited tissue distribution than other myc family genes and appears to be coexpressed with c-and/or N-myc (74) . During midgestation, high-level c-myc expression correlates well with active cellular proliferation, whereas strong N-and L-myc expression is also found in postmitotic cells that are undergoing differentiation. These expression profiles have fueled speculation that c-Myc plays a role in cellular proliferation whereas N-and L-Myc are more closely linked to processes of differentiation (43, 47, 48) , a hypothesis that has been supported by gain-of-function studies performed with transgenic mice (44) .
Homozygous null c-myc and N-myc mice die on embryonic days 10 and 12 (E10 and E12), respectively. Mice devoid of N-Myc exhibit a marked delay in development as well as a decrease in size and diminished cellularity of organs that normally express abundant levels of N-myc mRNA during their development (14, 58, 66) ; in particular, the cranial and spinal ganglia, mesonephros, lung, and gut were most severely affected (14, 58, 66) . Abnormalities appear despite compensatory up-regulation of c-myc in the neuroepithelium (66), a tissue that normally expresses N-myc, a finding suggesting a unique and essential role for N-Myc at this stage in development. Similarly, although N-myc expression is strong in many cell types during early gestation, this does not rescue the homozygous null c-myc condition, whose embryonic lethality is associated with a marked reduction in embryo size and a generalized delay in the early development of multiple organs, including the heart, the pericardium, and the neural tube, potentially due to a defect in vascularization (16) . Perhaps the most unexpected result of the c-and N-myc studies was the survival of these mutant embryos to developmental stages well beyond the onset of abundant c-and N-myc expression. Redundant functional properties among members of the Myc family during early, but not later, embryonic development could provide a potential explanation for the survival of mutant embryos through early embryonic stages (14, 16, 58, 66) . Indeed, molecular complementation appears to be the case, as embryos null for max, the obligate partner of all three Myc oncoproteins, become arrested much earlier in development than null c-or N-myc embryos (35a) .
In this study, we have examined L-myc gene expression during normal mouse development and used gene targeting methodology to produce a loss-of-function mutation in the L-myc gene with the goal of determining the developmental role of L-Myc and its functional relationship to other members of the Myc family. RNA in situ hybridization studies show that L-myc is expressed throughout the developing central nervous system with the highest levels detected in the neuroectoderm of the brain and neural tube. Despite this expression and the postulated role of L-myc as a pivotal developmental regulator of neuronal differentiation, homozygous null L-myc mice are healthy and indistinguishable from their wild-type littermates. The functional implications of L-Myc's dispensability are discussed.
MATERIALS AND METHODS
Detection of embryonic expression of L-myc by in situ hybridization. Embryos were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) and embedded in paraffin. Sections (3 to 4 m thick) were cut and affixed to poly-L-lysine-coated slides. Sense and antisense 35 S-labeled riboprobes were generated from appropriately linearized plasmids by in vitro transcription with T3 and T7 RNA polymerases (Stratagene) and 35 S-UTP under standard conditions. The L-myc probe (pTL180.72) contained a 180-bp PstI fragment derived from untranslated sequences in exon 3 cloned into the vector pT7T3 19U. The N-myc probe (pMN1.2) was a 540-bp ClaI-PstI fragment from the third exon of N-myc cloned into pSP65. The c-myc probe (pKSc370) was a 370-bp PvuII-XhoI fragment from the third exon cloned into pBluescript. Slide pretreatment and in situ hybridization were performed as previously described (40) . The slides were exposed to Kodak NTB-2 emulsion and developed after 14 to 30 days. Cell culture and electroporation of ES cells. Mouse embryonal stem (ES) cells were maintained as previously described (55) and cultured in Dulbecco's modified Eagle's medium supplemented with 15% fetal calf serum (Sigma) and 1,000 U of leukemia inhibitory factor per ml on ␥-irradiated SNL feeder layers (a kind gift from Allan Bradley). The mouse ES cell line used was E14a, derived by Martin Hooper (24) and provided by Raju Kucherlapati. Details regarding the design of the L-myc targeting construct are described in the legend to Fig. 3 . For electroporation, 5 ϫ 10 7 cells were trypsinized, washed in PBS, resuspended in 0.8 ml of PBS containing 10 to 25 g of linearized L-myc/Neo/Tk vector (see Fig.  3A ), and incubated on ice for 5 to 10 min. Electroporation was performed in a 0.4-cm-diameter cuvette by using a Bio-Rad gene pulser at 250 mV and 500 F. Following a 10-min incubation at room temperature, electroporated ES cells were plated onto 10 6-cm-diameter tissue culture plates containing the medium described above. Thirty-six to 50 h later, two plates received G418 (0.125 mg/ml; active ingredient); the remaining eight plates received both G418 (0.125 mg/ml; active ingredient) and ganciclovir (2 M [final concentration]). On day 5 of selection, the G418 dose was increased to 0.15 mg/ml (active), and selection was continued for an additional 4 to 5 days. On days 9 and 10 of selection, individual clones were picked, dispersed into a single cell suspension in 0.25% trypsin-1 mM EDTA, and seeded into two wells, each in a separate 48-well tissue culture plate. After 5 to 7 days, one plate was used for DNA isolation for Southern analysis by standard protocols. The ES cultures in the duplicate plate were frozen by slow cooling to Ϫ80ЊC following replacement of ES culture medium with 200 l of ice-cold DMEM containing 10% FCS and 10% dimethyl sulfoxide.
Blastocyst injections. Approximately 10 to 15 ES cells carrying one null allele of the mouse L-myc gene were microinjected into C57BL/6 blastocysts; five to seven microinjected embryos were transferred into each uterine horn of a CD1 pseudopregnant female at 2.5 days postcoitum. The degree of chimerism was determined by agouti coat color contribution.
Analysis of DNA and RNA. To distinguish between wild-type and targeted L-myc alleles, Southern blots containing BamHI-digested genomic DNA derived from 1 well of a 48-well plate were assayed for hybridization with a radiolabeled 800-bp EcoRI fragment containing 5Ј flanking L-myc genomic sequences located beyond the 5Ј end of the L-myc/Neo/Tk vector. For Northern (RNA) blot studies, total cellular RNA derived from staged whole mouse embryos and from newborn mouse tissues was isolated by the LiCl method as described previously (3). Embryos were staged as 0.5 days at noon of the day on which the vaginal plug was found. Twenty micrograms of total RNA was used in each lane and was judged to be intact and evenly loaded by ethidium bromide staining and by hybridization with the rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene (69) . Following hybridization with c-, N-, or L-myc-specific probes, the same filter was assayed for hybridization with GAPDH as a control for sample loading. To compare myc family gene expression between wild-type and null L-myc samples, quantitation of hybridization signals was performed with the aid of the Molecular Dynamics model 300 series computing densitometer program Imagequant. Probes used for Northern blot studies included the following: (i) for c-myc, a 780-bp PstI-XhoI coding domain fragment derived from pMc-myc54 (67) (a gift from Ken Marcu); (ii) for N-myc, a 560-bp ClaI-PstI exon 3 fragment isolated from pN77 (18); and (iii) for L-myc, a 560-bp BamHI-HindIII exon 3 fragment isolated from B1 (36) .
Histological analysis, bromodeoxyuridine (BrdU) assays, and indirect immunoperoxidase staining. Staged whole embryos or 2-month-old adult organs were fixed in 10% buffered formalin (Polyscientific) overnight, dehydrated through a graded ethanol series, cleared in xylene, and embedded in Paraplast Xtra (VWR). Microtome sections (5 m thick) were affixed to poly-L-lysine-coated microslides, deparaffinized, rehydrated, and blocked with normal goat serum (Vector Laboratories). Neuronal development was evaluated by immunocytochemical staining of paraffin sections with an antiserum raised specifically against a 66-kDa neurofilament protein, NF-66, that is abundantly expressed in both embryonic and postnatal brain neurons. NF-66 and the polyclonal rabbit antiserum were described elsewhere (15) . Primary incubations were carried out with antiserum at a 1:1,000 dilution for 2 h at room temperature in 5% bovine serum albumin-PBS. The secondary incubations were carried out with biotinylated anti-rabbit serum (Vector Laboratories) at a 1:200 dilution for 1 h at room temperature and were followed by avidin and peroxidase-conjugated biotin detection (Vector Laboratories). The analysis of cellular proliferation (progression through S phase) of 15.5-day-old embryos was performed as described elsewhere (44) .
Antibody preparation and Western immunoblot analysis.
A mouse L-Mycspecific carboxy-terminal peptide (CRQQQLQKRIAYLSGY) was synthesized, purified by high-pressure liquid chromatography, and verified by mass spectrophotometry by the Macromolecular Analysis Facility at the Albert Einstein College of Medicine. Peptides were coupled via their N-terminal cysteine residues to maleimide-activated keyhole limpet hemocyanin by using an Imject Activated Immunogen Conjugation Kit (Pierce). Male New Zealand White rab-VOL. 16, 1996 L ). The pellets containing the nuclei were homogenized in 3% sodium dodecyl sulfate (SDS), and protein concentrations were analyzed by the method of Lowry et al. (37, 51) . Protein samples were separated by SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to nitrocellulose membranes. Membranes were blocked by incubation in PBS containing 10% nonfat dry milk and 0.1% Tween 20 (diluent) for 1 h at 37ЊC and then rinsed several times in PBS. Primary incubations of membranes were carried out with affinity-purified antibody at a 1:200 dilution in diluent, and secondary incubations were carried out with horseradish peroxidase-conjugated donkey anti-rabbit whole immunoglobulin G serum at a 1:5,000 dilution. Immunoreactive bands were visualized with an enhanced chemiluminescence kit (Amersham). Controls for nonspecific binding were prepared by preincubating the anti-L-Myc antiserum (at 1:50 dilutions) with its corresponding synthetic peptide linked to agarose beads (Ag/Ab Immunobilization Kit 2; Pierce) for 48 h at 4ЊC. After centrifugation, a 1:200 dilution of the supernatant was used as the primary antibody in place of the affinitypurified antibody.
Detection of cytoplasmic pigmented granules in neurons by EM. Animals were anesthesized and perfused with PBS followed by Trump's fixative. The cerebellum was dissected, postfixed for 30 min, dehydrated, and embedded in Epon. Preliminary sagittal sections were cut, mounted on microslides, and stained for light microscopy, and areas with appropriate structures were identified. The cervical spinal chord (about C1-2) was dissected and similarly processed. Spinal cords were cut into cross sections at angles perpendicular to the long axis. The Epon blocks were then trimmed with reference to the test sections, and EM sections were cut and mounted on Formvar-coated EM grids. Cerebellar Purkinje neurons were identified by the following criteria: their location in between the molecular and granular layers, their large size, the presence of apical dendrites, and the presence of the apical depression in the nuclear membrane (the nuclear depression is often filled with Golgi apparatus endoplasmic reticulum). Ventral motor neurons were identified by location and size. In both Purkinje neurons and ventral motor neurons, the number of cytoplasmic pigmented granules, identified by their darker staining compared with the staining of mitochondria, per neuron was counted. Only neurons visible as whole cells were analyzed. Neurons that were partially obscured (by the EM grid, for example) were not included in the analysis.
RESULTS
L-myc gene expression in the developing mouse embryo. The cellular expression of L-myc from early (E9.5) through midgestational (E15.5) stages of mouse development was determined by RNA in situ hybridization. At E9.5, the most prominent signals were detected throughout the neuroectoderm of the brain and neural tube (Fig. 1) . By E12.5 and thereafter, abundant L-myc transcripts persisted throughout the central nervous system (CNS) and were also detected in the nasal epithelium, the metanephric kidney, and the developing lung buds (Fig. 2 and data not shown) . These findings are in accord with those derived from previous Northern blot analyses, demonstrating that the newborn brain, kidney, and lung exhibit the highest levels of steady-state L-myc mRNA (74) . Although the entire CNS was labeled in E12.5 ( Fig. 2A to D) and E15.5 ( Fig.  2E and F) embryos, some variation in labeling intensity was noted in certain areas with maturation of the CNS. For example, the ventral diencephalon (hypothalamus) ( Fig. 2A and B) was labeled only slightly above the background, while other regions of the diencephalon, the telencephalon, and the neural tube were more strongly labeled (Fig. 2C and D) . Similarly, the neuroepithelium of the medial cortex and septal areas of the telencephalon showed stronger signals than the more-lateral cortex and ganglionic eminence (Fig. 2E and F) . Notably, Lmyc expression was detected in the periventricular zone where cell proliferation takes place, as well as in more-lateral postmitotic regions (intermediate zone) where differentiation occurs. However, the most robust expression of L-myc was seen in the sensory nasal (olfactory) epithelium ( Fig. 2G and H) . Expression was also detected in the epithelium of the esophagus, trachea, thymic rudiment, and liver at 15.5 days (data not shown). Consistent with previous studies, strong L-myc expression in the developing metanephric kidney at midgestation localized to the large papillary ducts of the collecting duct system, papilla, renal pelvis, and ureter (data not shown) (48) . These previous studies also demonstrated that L-myc expression persists in the adult ureter, wherein the continual renewal of epithelium takes place (48) . The localization of L-myc ex- (Fig. 3A) . Two modifications served to disrupt the L-myc open reading frame. First, a 19-bp oligonucleotide introduced a BamHI site and a translational terminator into the second-exon region encoding the amino-terminal transactivation domain. Second, a third-exon 1.4-kb BamHI-XhoI fragment encoding nuclear localization, bHLH/LZ, and some 3Ј untranslated sequences was replaced completely by the neomycin resistance (Neo r ) gene under the control of the phosphoglycerokinase 1a (pgk) promoter and polyadenylation signal. A pgk-driven herpes simplex virus thymidine kinase gene was placed in a flanking position to permit selection, in the presence of ganciclovir, against random integration events.
All of the mutant ES cells used to generate null L-myc mice were derived from two electroporations of 5 ϫ 10 7 cells each as detailed in Materials and Methods. In the two electroporations, selection generated approximately 5,600 and 3,600 Neomycin-resistant colonies versus 925 and 1570 doubly resistant colonies, respectively, yielding enrichments of 6.1-and 2.3-fold by counterselection. A total of 217 doubly resistant clones were subjected to Southern blot analysis. In a homologous recombination event, L-myc-Neo r gene integration results in (i) the introduction of a BamHI site in the second exon that decreases a BamHI genomic band from 12 kb to 8.7 kb and (ii) the deletion of the bHLH/LZ region of the third-exon sequences detected by probe B (Fig. 3A) , producing a null allele. Four mutant clones that contained restriction fragment length alterations consistent with a targeted event were identified (see below). Injections into C57BL/6 blastocysts generated chimeric mice with agouti coat color contributions ranging from 30 to 100%. Upon mating with C57BL/6 partners, chimeric mice generated with three of these clones produced agouti offspring harboring the mutant L-myc allele.
L-Myc-deficient mice are viable and apparently healthy. To ascertain whether L-Myc plays an essential role in development, genotype distribution was determined for offspring generated from heterozygous null L-myc intercrosses. All three genotypes were represented (Fig. 3B, probe A) , and they were distributed at a ratio of 1:2:1 for both 100 embryos spanning E9.5 through E18.5 and over 300 live offspring. There were no consistent congenital defects that correlated with a specific genotype in the embryonic and adult samples, as assessed by visual inspection and more detailed studies (see below). In addition to a normal genotype distribution, the likelihood that perinatal lethality was associated with L-Myc deficiency was ruled out by careful monitoring of the births of many litters. The homozygous null L-myc mice have a life span comparable to that of their heterozygous and wild-type littermates, surviving over 2 years without evidence of specific physiological compromise. Furthermore, examination of the genotypes resulting from spontaneous deaths in the total mouse population over a 3-year period revealed that the homozygous null L-myc mice were not overrepresented or underrepresented in this subpopulation. Homozygous null L-myc mice produced phenotypically normal offspring. Given the lack of a gross impact on viability, disruption of the L-myc gene was verified on three levels. By Southern analysis, L-myc exon 3 sequences that were replaced by the Neo r gene were completely absent from the homozygous null mouse genome, as determined by hybridization with probe B (Fig. 3B, probe B, lane 4). Similarly, Northern blot studies of a panel of newborn tissues derived from homozygous null L-myc mice failed to detect L-myc transcripts when the probe directed to the deleted L-myc sequences (probe B) was used (Fig. 3C) . Lastly, Western blotting demonstrated that the 62-kDa-68-kDa L-Myc protein doublet was absent in homozygous null L-myc brain lysates ( Fig. 3D ; compare starred bands in lane 1 with lane 2).
Normal growth and morphological development in L-Mycdeficient mice. An extensive histological survey was performed on adult tissues from wild-type and homozygous null L-myc mice with a particular emphasis on tissues that express L-myc during development-those of the forebrain, cerebellum, lung, kidney, and gastrointestinal tract. A comparative histological analysis of one pair of wild-type and null L-myc mice at E15.5, E18.5, and adult stages did not reveal any obvious differences in morphology or cellularity ( Fig. 4 ; only the adult stage is shown). In particular, cytoarchitecture and cell numbers were similar in the CNS (Fig. 4A and B) . In contrast to that of the lungs of mice homozygous for a hypomorphic allele of the N-myc gene (42) or a null N-myc mutation (58, 66) , the bronchiolar branching pattern of the lungs of L-Myc-deficient mice was normal and type I and type II pneumocytes were well represented (Fig. 4C) . The kidney had normal numbers of glomeruli and cortical thickness, and the collecting ducts appeared normal (Fig. 4D) . The morphology of the villi in the small intestine, as well as the liver, also appeared unaffected ( Fig. 4E and F, respectively) .
The observations that L-myc expression is deregulated in some naturally occurring tumors and that L-myc exhibits oncogenic activity in the rat embryo fibroblast assay prompted a detailed examination of cellular proliferation in embryonic tissues that normally express detectable levels of L-myc mRNA during development. A BrdU immunoperoxidase histochemical assay was used to visualize cells progressing through S phase in organs of 15.5-day-old embryos following a 1-h pulse with BrdU in utero. Comparison of wild-type and homozygous null L-myc littermates showed no obvious differences in numbers and distribution of S-phase nuclei in L-myc-expressing tissues such as those of the kidney, the periventricular zone in the cerebellar cortex, or the olfactory epithelium (Fig. 5) . Significantly, the strong labeling of the nasal epithelium in the in situ studies prompted a closer examination of the nasal epithelium. The nasal epithelium appeared normal upon gross examination in the homozygous null mice; however, this observation does not rule out some subtle changes in the olfactory epithelium that could escape detection by these methods. Additionally, these results support our previously stated hypothesis that L-Myc does not play a prominent role in the regulation of cellular proliferation during normal development (44) .
Studies with cell culture and during normal development have shown that dramatic changes in myc family gene expression often accompany key differentiation events, and aberrant expression of each myc family gene has been shown to impair differentiation in cell culture systems of differentiation and in transgenic mice (for a review, see reference 43). In particular, overexpression of L-myc in cultured neuroblasts has suggested a specific role for L-Myc in early CNS development as a factor that guides immature multipotent neuroblasts towards a neuronal rather than a glial cell type (7) . Although the histological survey of the adult CNS failed to uncover any defects in neuronal development, the developmental plasticity of the CNS could obscure early developmental perturbations. To this end, CNS development was assayed on the molecular level through an examination of neurofilament protein NF-66 expression during embryonic neuronal development. NF-66 was selected as a neuronal marker since it is abundantly expressed in neurons of embryonic and postnatal brain tissue and is highly specific and well characterized (15, 23) . Immunocytochemical studies of NF-66 clearly showed that its expression and distribution in neuronal cytoarchitecture were virtually indistinguishable between wild-type and homozygous null L-myc mice (Fig. 6 ). These findings, coupled with the normal histological appearance of the CNS, argue against an essential and unique role for L-Myc in early neuronal development.
The high level of L-myc gene expression in the developing mouse CNS (74) and the chromosomal localization of the human L-myc gene to the vicinity of the candidate locus for the infantile form of Batten's disease (CNL1) (26) prompted a careful ultrastructural examination of the brains of L-Mycdeficient mice for pathognomonic features of this disease. In humans, Batten's disease is characterized by progressive mental retardation, seizures, retinal degeneration, and cortical atrophy. On the cellular level, a hallmark pathological feature is the accumulation of clustered ceroid lipofuscin inclusions (reviewed in references 27 and 54), clearly evident in large neurons such as those of the cerebellum and the ventral motor horn of the spinal cord. Ultrastructural analysis of the cerebella and cervical spinal cords of age-matched wild-type and homozygous null L-myc adults did not detect any significant increase in the number or size of lipofuscin inclusions (data not shown). These findings are consistent with a recent report citing mutations in the closely linked palmitoyl protein thioesterase gene as the causative genetic alteration in the infantile form of Batten's disease (70) .
Expression of c-myc and N-myc genes in homozygous null L-myc tissues. The lack of a gross phenotype associated with L-Myc deficiency could be the result of compensation by other members of the Myc family. Indeed, disruption of the N-myc gene has been shown to be associated with a rise in the level of expression of c-myc in the neuroepithelium of the developing CNS (66) . In order to determine whether alterations in myc family gene expression occurred in homozygous null L-myc tissues, Northern blot and RNA in situ hybridization studies assayed the levels and patterns of c-and N-myc in tissues that normally express abundant levels of L-myc. Northern blot analyses of total RNA derived from the newborn brain, kidney, lung, and skin demonstrated that similar ranges of steady-state c-and N-myc expression were present in wild-type and null L-myc samples ( Fig. 7 ; only data for c-myc are shown). Simi- tine tissues). However, the studies described here, in which the L-myc gene was specifically disrupted by homologous recombination, demonstrate that L-myc joins an expanding list of genes whose inactivation fails to generate significant pathophysiological consequences (13, 56, 57) .
Homozygous null L-myc mice are viable and fertile and thrive well into adulthood. On the gross morphological level, tissues that normally express the L-myc gene were not affected by the loss of L-Myc. These results contrast with those observed previously for c-myc and N-myc mutations, wherein a homozygous null background was associated with embryonic lethality (14, 16, 58, 66) . Correspondingly, the normal neuronal (1, 11, 12, 23, 49, 71) and bind the same consensus recognition sequence, CACGTG (10, 25, 31, 39, 53) . In more-biological assays, transactivation-incompetent mutants of one Myc member act in trans to dominantly suppress the cotransformation activities of all three Myc oncoproteins, indicating that the Myc family members function through common genetic elements to transform normal cells (49) . Moreover, with respect to myc family gene expression in development, c-and N-myc exhibit distinct cell-type-specific differences in many organs (21, 47, 66, 74) , while L-myc is typically coexpressed with at least one other myc family gene (48, 74) . Consequently, the differential expression of c-and N-myc in developing organ systems may provide a basis for the midgestational lethality associated with homozygous null c-myc or N-myc genotypes, while the coordinate expression in the case of L-myc may facilitate its rescue by other members in L-Myc-deficient mice through elimination of the requirement for alterations in the cell-type-specific expression of c-or N-myc. Finally, the negligible effect of the loss of L-Myc may relate to its relatively weak transactivation potential (17) and its possible role as a subtle regulator of Mycresponsive growth and differentiation genes. In this regard, the principal role of L-Myc may be to function as an attenuator, rather than an activator, of these Myc-responsive gene targets, serving to modulate the regulatory activities of the more potent c-and N-Myc proteins. In this case, the loss of a negative regulator may have few consequences for development and may be manifested only as an enhanced predisposition to Mycinduced malignant disease, a possibility that remains to be determined. Such a precedent has been established for an important negative regulator of cell cycle progression, the p53 tumor suppressor gene product (20) . If this alternative explanation is correct, compensatory mechanisms for the loss of L-Myc may have little or no impact on the expression of c-and N-myc in tissues which normally express L-myc; this prediction is substantiated by results obtained in expression studies of the developing and newborn tissues of the homozygous null L-myc mouse (see above).
Complementary and distinct activities of members of the Myc family will be further clarified by the production and phenotypic analysis of homozygous null c-and/or N-myc genotypes against an L-Myc-deficient background. The outcome of such experiments will be particularly useful for discerning the potential role of the Myc family in early embryonic growth and development. These studies, coupled with the analysis of mice deficient in Max or Max-associated proteins (Mad and Mxi1), will also help to elucidate how this network of molecules interacts and functions to bring about orchestrated patterns of developmental gene expression during mammalian embryogenesis.
